OGEVITY
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Dec 2022)
What this means for you
This application is over — abandoned 05 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88897981
- Mark type
- Stylized text
- Filed
- 01 May 2020
- Published for opposition
- 08 Sept 2020
- Abandoned
- 05 Dec 2022
- Attorney of record
- Leslie H Smith
Goods and services
- Class 005 — Pharmaceuticals: House mark for a full line of therapeutic pharmaceutical, pharmaceutical, medical and veterinary preparations; therapeutic pharmaceutical and pharmaceutical preparations for treatment or prevention of systemic diseases, cardiovascular diseases, neurodegenerative diseases, metabolic syndrome, diabetes mellitus, obesity, cancer, oncology, dyslipidemia, infectious diseases, degenerative and inflammatory diseases, urologic diseases, sexual dysfunction, osteoporosis, sepsis, hepatitises, and HIV/AIDS; transdermal preparations, namely, transdermal creams for delivery of pharmaceuticals; anti-inflammatory preparations; antiseptic preparations; topical analgesic creams; anesthetic spray for topical use; decongestants; antifungal preparations; anti-infective pharmaceutical preparations
Owner
- Ogevity Therapeutics, Inc., Concord, NC, US
- Ogevity Therapeutics, Inc., Concord, NC, US
Prosecution history
- 05 Dec 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Dec 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2022 — SOU EXTENSION 3 GRANTED
- 20 Apr 2022 — SOU EXTENSION 3 FILED
- 20 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 11 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Nov 2021 — SOU EXTENSION 2 GRANTED
- 01 Nov 2021 — SOU EXTENSION 2 FILED
- 01 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 02 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jun 2021 — CORRECTED NOA E-MAILED
- 01 Jun 2021 — DIVISIONAL PROCESSING COMPLETE
- 28 Apr 2021 — DIVISIONAL REQUEST RECEIVED
- 01 Jun 2021 — SOU EXTENSION 1 GRANTED